We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
+13.42%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$558M
Cap. Flow
+$437M
Cap. Flow %
27.05%
Top 10 Hldgs %
34.09%
Holding
582
New
73
Increased
454
Reduced
38
Closed
16

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$29.1M
2
AAPL icon
Apple
AAPL
+$26.2M
3
NVDA icon
NVIDIA
NVDA
+$19.5M
4
AMZN icon
Amazon
AMZN
+$16.9M
5
META icon
Meta Platforms (Facebook)
META
+$10.3M

Top Sells

Rank Stock Value
1
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$12.5M
2
SPLK
Splunk Inc
SPLK
+$848K
3
GS icon
Goldman Sachs
GS
+$583K
4
IMGN
Immunogen Inc
IMGN
+$523K
5
TRV icon
Travelers Companies
TRV
+$514K

Sector Composition

Rank Sector Weight
1 Technology 34.78%
2 Healthcare 14.59%
3 Communication Services 10.45%
4 Consumer Discretionary 10.42%
5 Financials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAL icon
526
American Airlines Group
AAL
$8.52B
$240K 0.01%
+15,656
New +$227K
MOS icon
527
The Mosaic Company
MOS
$8B
$240K 0.01%
+7,382
New +$235K
MTCH icon
528
Match Group
MTCH
$10.2B
$239K 0.01%
+6,587
New +$238K
HRL icon
529
Hormel Foods
HRL
$11.5B
$239K 0.01%
+6,848
New +$218K
L icon
530
Loews
L
$22.3B
$237K 0.01%
+3,030
New +$224K
IEX icon
531
IDEX
IEX
$16.5B
$237K 0.01%
972
-17
-2% -$3.84K
NWSA icon
532
News Corp Class A
NWSA
$16.2B
$237K 0.01%
+9,051
New +$230K
ROL icon
533
Rollins
ROL
$16.3B
$235K 0.01%
+5,084
New +$224K
ITCI
534
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$234K 0.01%
+3,388
New +$233K
NCLH icon
535
Norwegian Cruise Line
NCLH
$6.58B
$223K 0.01%
+10,639
New +$193K
EPAM icon
536
EPAM Systems
EPAM
$6.19B
$222K 0.01%
805
-12
-1% -$3.53K
ESS icon
537
Essex Property Trust
ESS
$17.8B
$219K 0.01%
894
-14
-2% -$3.33K
SNA icon
538
Snap-on
SNA
$19.5B
$218K 0.01%
736
-12
-2% -$3.41K
AVY icon
539
Avery Dennison
AVY
$13.2B
$217K 0.01%
972
-19
-2% -$3.94K
RCUS icon
540
Arcus Biosciences
RCUS
$3.13B
$217K 0.01%
11,477
+336
+3% +$5.81K
POOL icon
541
Pool Corp
POOL
$6.19B
$217K 0.01%
537
-9
-2% -$3.52K
ZBRA icon
542
Zebra Technologies
ZBRA
$16.3B
$215K 0.01%
+712
New +$191K
XENE icon
543
Xenon Pharmaceuticals
XENE
$5.58B
$214K 0.01%
+4,972
New +$229K
TECH icon
544
Bio-Techne
TECH
$11.3B
$213K 0.01%
+3,028
New +$217K
CZR icon
545
Caesars Entertainment
CZR
$6.05B
$213K 0.01%
+4,869
New +$211K
LH icon
546
Labcorp
LH
$26.3B
$213K 0.01%
973
-21
-2% -$4.63K
ACLX
547
DELISTED
Arcellx
ACLX
$212K 0.01%
+3,053
New +$194K
TSM icon
548
TSMC
TSM
$2.17T
$209K 0.01%
+1,537
New +$191K
NDSN icon
549
Nordson
NDSN
$17.3B
$208K 0.01%
756
-12
-2% -$3.13K
NUVL
550
DELISTED
Nuvalent
NUVL
$207K 0.01%
+2,758
New +$219K
20 21
22
23 24

Similar funds

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $26.8B AUM 90.85% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

NEOS Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, NEOS Investment Management held 582 positions worth $1.61B, up 53% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

NEOS Investment Management deployed $437M of net new capital in Q1 2024, opening 73 new positions and adding to 454 existing holdings. Its largest new stake was Keros Therapeutics: 14,264 shares worth $944K.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Goldman Sachs, an estimated $583K trimmed.

  • NEOS Investment Management's largest Q1 2024 buy was Keros Therapeutics: 14,264 shares worth $944K.
  • NEOS Investment Management added most to Microsoft in Q1 2024, an estimated $29.1M increase.
  • NEOS Investment Management's biggest Q1 2024 reduction was Goldman Sachs, cutting an estimated $583K.
  • NEOS Investment Management fully exited Vanguard Russell 2000 ETF in Q1 2024, selling an estimated $12.5M.
  • NEOS Investment Management's ten largest holdings make up 34% of its $1.61B portfolio in Q1 2024.
  • NEOS Investment Management opened 73 new positions and closed 16 in Q1 2024.
  • NEOS Investment Management's portfolio value rose 53% quarter-over-quarter to $1.61B.

Based on NEOS Investment Management's 13F filing for Q1 2024, filed 13 May 2024.